BiotecnomedBiotecnomedBiotecnomedBiotecnomed
  • No Menu Set

GENADIS-D

Role of nutraceutical supplementation with antioxidants in women candidates for medically assisted procreation techniques.

 

Description: GENADIS-D is a project aimed at developing a nutraceutical in the female and male infertility sector with a view to its industrialization by Merck Serono.

There are currently no therapeutic strategies that improve success rates in infertile women of advanced reproductive age. Some of the hypotheses consider a deficit in the androgen production of the ovary or the appearance of a mitochondrial dysfunction at the origin of reproductive senescence in women. In this context, The use of D-Aspartic acid and melatonin seems particularly promising as it exerts an effect in preserving the integrity of granulosa cells from damage induced by oxidative stress.

The data available in the literature suggest, Therefore, such as the supplementation of these compounds, combined with coenzyme Q, may produce a positive effect in older women undergoing PMA techniques.

The project consists of confirming these scientific assumptions through in vitro and in vivo studies of the D-aspartic acid association, melatonin, coenzyme Q which will be conducted mainly by the university partner. The formulation study will allow us to identify the best mixture. The formulated product will be developed by Merck Serono up to pilot scale.

The final objective is the development of a nutraceutical in the field of female and male infertility with a view to its launch on the market by Merck Serono. The DMSC of the Magna Graecia University participate in the project with the aim of evaluating the impact of the administration of the nutraceutical proposed by Merck Serono both in terms of direct effects on gametic quality, both in terms of improvements in the reproductive chances of couples treated with PMA cycles. The study and classification of such data, through bioinformatics analysis and integration tools, will be performed by Biotecnomed.

 

Project partners:

  • Biotecnomed S.c.a r.l.
  • Merck Serono S.p.A.
  • Magna Graecia University of Catanzaro

Funds: I&C 2014-2020

 

Total investment: € 3.114.491,25

Total contribution: € 1.513.976,58

 

Period: 2020 – 2023

The project was co-financed by the European Union - European Regional Development Fund, within the National Operational Program «Enterprises and Competitiveness» 2014-2020 – Asse 1 Investment Priorities 1.b Action 1.1.3 – in favor of industrial research and experimental development projects in the application sectors consistent with the National Smart Specialization Strategy "Intelligent Factory" and "Agrifood" - Ministerial Decree. 5 March 2018 e D.D. 27 September 2018.

 

Profile

  • Biotecnomed
  • The Innovation Pole of Health Technologies
  • The District's Health and Biotechnology
  • Research and Development Projects
  • Il Team
  • How to join
  • transparent Administration
Privacy Policy

Services

  • Research and development
  • Intellectual property
  • Research Services
  • Events and training
  • Maker space
  • settlement offer

Areas and laboratories

  • Regenerative Medicine
  • advanced Diagnostics
  • neuromotor rehabilitation
  • Nutraceuticals and Functional Foods
Invitalia Partner Startup Catanzaro
Invitalia Startup System Partner 2023
Logo tech4you
Copyright 2016-2022 © Biotecnomed S.c.a.r.l. | P. IVA 03152670794
  • transparent Administration
  • Application areas and laboratories
    • advanced Diagnostics
    • Regenerative Medicine
    • Nutraceuticals and Functional Foods
    • neuromotor rehabilitation
  • Biotecnomed: instruments, ideas and resources for growth in the health technologies industry
  • Contacts
  • Become part of the most important Calabrian system of life sciences
  • Home
  • The District's Health and Biotechnology
  • The Innovation Pole of Health Technologies
  • Il Team
  • Work with us
  • News & Media
  • Patent Portfolio
  • Research and Development Projects
    • ABRAM – Advanced biosafety in tissues regeneration and in biomedicine
    • ALIFUD – Development of new functional foods effective for women's health in post-menopausal osteoporosis
    • CATANZARO 4.0
    • Creating a Safe Home Environment
    • OEDIPUS
    • GENADIS-D
    • Hearthdrive – Advanced services for more effective and efficient integrated clinical management of heart failure and its main comorbidities
    • ICaRe – Calabrian Infrastructure for regenerative medicine: generation of bio-banks for the cryopreservation of human stem cells and bone tissue for clinical use and design and development of innovative bioscaffold
    • Locubirehab – Low cost ubiquitous rehab assistant
    • MATE
    • I PRAY
    • NADITEMM
    • Neuromeasures – Development of innovative processes and to support the early diagnosis of motor disorders services, behavioral and mnesici in Parkinson's disease and Alzheimer's disease
    • Optima Cardiopaths – Innovative tools for optimizing clinical management and endovascular therapy of cardiovascular diseases
    • Innovation Pole of Health Technologies 2018-2023
    • Merck project
    • Tech4You
    • A device and a method for installing a plug in a wall
    • WEEPIE
  • Integrated services of research and innovation to improve the quality of life and health of citizens
    • Events and training
    • Maker space
    • settlement offer
    • Intellectual property
    • Research and development
    • Research Services
Biotecnomed